VistaGen Therapeutics, Inc. (VTGN)
NASDAQ·Healthcare·Biotechnology
$0.24
+4.34%
Mkt Cap $18.72M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$0.95
Range $0.90 – $1.00
Implied Upside
+291.1%
Consensus $0.95 vs current $0.24
NASDAQ·Healthcare·Biotechnology
$0.24
+4.34%
Mkt Cap $18.72M
No recent rating data.
Price Target (4 analysts)
$0.95
Range $0.90 – $1.00
+291.1%
Consensus $0.95 vs current $0.24